Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PLETHICO PHARMA   ACTAVIS
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
ACTAVIS
Dec-18
PLETHICO PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs25416,159-   
Low Rs3110,840-   
Sales per share (Unadj.) Rs604.63,963.8-  
Earnings per share (Unadj.) Rs32.5-1,276.8-  
Cash flow per share (Unadj.) Rs51.3417.7-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs473.716,349.0-  
Shares outstanding (eoy) m34.07332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.23.4 6.9%   
Avg P/E ratio x4.4-10.6 -41.5%  
P/CF ratio (eoy) x2.832.3 8.6%  
Price / Book Value ratio x0.30.8 36.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m4,8594,489,898 0.1%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m1,5470-   
Avg. sales/employee Rs Th078,010.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,127.1-  
INCOME DATA
Net Sales Rs m20,5981,318,372 1.6%  
Other income Rs m41925,212 1.7%   
Total revenues Rs m21,0171,343,584 1.6%   
Gross profit Rs m2,93834,548 8.5%  
Depreciation Rs m642563,576 0.1%   
Interest Rs m1,74776,078 2.3%   
Profit before tax Rs m968-579,893 -0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,896 0.0%   
Tax Rs m-138-7,349 1.9%   
Profit after tax Rs m1,107-424,648 -0.3%  
Gross profit margin %14.32.6 544.3%  
Effective tax rate %-14.31.3 -1,127.6%   
Net profit margin %5.4-32.2 -16.7%  
BALANCE SHEET DATA
Current assets Rs m18,877540,727 3.5%   
Current liabilities Rs m11,896478,345 2.5%   
Net working cap to sales %33.94.7 716.2%  
Current ratio x1.61.1 140.4%  
Inventory Days Days7820 398.9%  
Debtors Days Days19866 298.3%  
Net fixed assets Rs m14,269149,232 9.6%   
Share capital Rs m3410-   
"Free" reserves Rs m15,7980-   
Net worth Rs m16,1395,437,670 0.3%   
Long term debt Rs m4,7061,914,801 0.2%   
Total assets Rs m33,1468,500,316 0.4%  
Interest coverage x1.6-6.6 -23.5%   
Debt to equity ratio x0.30.4 82.8%  
Sales to assets ratio x0.60.2 400.7%   
Return on assets %8.6-4.1 -209.9%  
Return on equity %6.9-7.8 -87.8%  
Return on capital %13.0-4.8 -269.1%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Net fx Rs m1,2190-   
CASH FLOW
From Operations Rs m2,437471,005 0.5%  
From Investments Rs m-6,265258,756 -2.4%  
From Financial Activity Rs m2,490-808,385 -0.3%  
Net Cashflow Rs m24-78,232 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare PLETHICO PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PLETHICO PHARMA With: BLISS GVS PHARMA  ZIM LABORATORIES  SANDU PHARMA  ANG LIFESCIENCES INDIA  HEMO ORGANIC  



Today's Market

Gift Nifty Up 42 Points | Cipla Buys Ivia Beauty Brands | India's Green Power Push | Top Buzzing Stocks Today Gift Nifty Up 42 Points | Cipla Buys Ivia Beauty Brands | India's Green Power Push | Top Buzzing Stocks Today(Pre-Open)

Indian share markets Slipped further as the session progressed and ended the day weak.